Taking the right chances
Regulatory reach is extending further, the price we might have to pay for growth is higher than ever and, economically, we’re still on uncertain ground. Is it all worth the risk?
adapt and evolve
Risk, as we once knew it, has changed. When a crisis hits, the pressure to respond is enormous. Companies need to be prepared.
We need to address Europe’s failing economic policy, argue Alistair Darling and Peter Bofinger.
The boom continues
US M&A is on pace to post its best performance since 2007
US M&A market proves record 2014 was no one-off
H1 2015 saw US$753.3 billion worth of deals, up from US$598 billion in H1 2014
Sector watch: The usual suspects lead the way in M&A
As in 2014, the TMT and pharma, medical and biotech sectors accounted for the lion’s share of overall deal value
CFIUS reality check: Seven insights for Chinese investors
Rules of thumb for navigating US national security reviews
US M&A in figures
Infographic: Charting the latest trends
Private equity pulls back in 2015
Market forces have led buyout firms to exercise restraint
Looking ahead: All eyes on H2 and beyond
Considerations for dealmakers pursuing future transactions
“It’s a booming M&A market because we have booming valuations. Valuations are high because there is a strong stock market.”
John Reiss, Global Head of M&A, White & Case
US M&A H1 2015: Riding high
US M&A is booming—continuing the record-breaking trends from last year